ATG in allogeneic stem cell transplantation: standard of care in 2017? Counterpoint

Natasha Kekre; Joseph H Antin

doi:10.1182/bloodadvances.2016001552

ATG in allogeneic stem cell transplantation: standard of care in 2017? Counterpoint

Blood Adv. 2017 Mar 28;1(9):573-576. doi: 10.1182/bloodadvances.2016001552.

Authors

Natasha Kekre¹, Joseph H Antin²

Affiliations

¹ Blood and Marrow Transplant Program, The Ottawa Hospital, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada; and.
² Stem Cell Transplantation Program, Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.

Abstract

Publisher's Note: This article has a companion Point by Bacigalupo. Publisher's Note: Join in the discussion of these articles at Blood Advances Community Conversations.